Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO. Banks SA, et al. Among authors: koster mj. Ophthalmology. 2023 Sep;130(9):e33-e34. doi: 10.1016/j.ophtha.2023.05.017. Epub 2023 Jun 10. Ophthalmology. 2023. PMID: 37306648 No abstract available.
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Heiblig M, Ferrada MA, Koster MJ, Barba T, Gerfaud-Valentin M, Mékinian A, Coelho H, Fossard G, Barraco F, Galicier L, Bienvenu B, Hirsch P, Vial G, Boutin AB, Galland J, Le Guenno G, Bigot A, Warrington KJ, Kermani TA, Grayson PC, Patel BA, Beck DB, Jamilloux Y, Fenaux P, Sujobert P. Heiblig M, et al. Among authors: koster mj. Blood. 2022 Aug 25;140(8):927-931. doi: 10.1182/blood.2022016642. Blood. 2022. PMID: 35609174 Free PMC article.
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F, Kumar DBU, Wilson L, Goodspeed W, Topilow JS, Paik JJ, Poulter JA, Kermani TA, Koster MJ, Warrington KJ, Cargo C, Tattersall RS, Duncan CJA, Cantor A, Hoffmann P, Payne EM, Bonnekoh H, Krause K, Cowen EW, Calvo KR, Patel BA, Ombrello AK, Kastner DL, Young NS, Werner A, Grayson PC, Beck DB. Ferrada MA, et al. Among authors: koster mj. Blood. 2022 Sep 29;140(13):1496-1506. doi: 10.1182/blood.2022016985. Blood. 2022. PMID: 35793467 Free PMC article.
Efficacy of biological agents in the treatment of Erdheim-Chester disease.
Goyal G, Shah MV, Call TG, Litzow MR, Wolanskyj-Spinner AP, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Hook CC, Hogan WJ, Go RS. Goyal G, et al. Among authors: koster mj. Br J Haematol. 2018 Nov;183(3):520-524. doi: 10.1111/bjh.14997. Epub 2017 Oct 30. Br J Haematol. 2018. PMID: 29082516 Free article. No abstract available.
Arterial involvement in Erdheim-Chester disease: A retrospective cohort study.
Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, Go RS, Koster MJ. Villatoro-Villar M, et al. Among authors: koster mj. Medicine (Baltimore). 2018 Dec;97(49):e13452. doi: 10.1097/MD.0000000000013452. Medicine (Baltimore). 2018. PMID: 30544428 Free PMC article.
Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.
Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Among authors: koster mj. Blood. 2019 Apr 4;133(14):1607-1610. doi: 10.1182/blood-2018-12-893917. Epub 2019 Jan 29. Blood. 2019. PMID: 30696619 Free PMC article. Review. No abstract available.
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.
Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Among authors: koster mj. Mayo Clin Proc. 2019 Oct;94(10):2054-2071. doi: 10.1016/j.mayocp.2019.02.023. Epub 2019 Aug 28. Mayo Clin Proc. 2019. PMID: 31472931
Low-dose vemurafenib monotherapy in BRAFV600E -mutated Erdheim-Chester disease.
Ruan GJ, Hazim A, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Young JR, Shah MV, Goyal G, Go RS. Ruan GJ, et al. Among authors: koster mj. Leuk Lymphoma. 2020 Nov;61(11):2733-2737. doi: 10.1080/10428194.2020.1783447. Epub 2020 Jul 1. Leuk Lymphoma. 2020. PMID: 32608295 Free PMC article. No abstract available.
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.
Goyal G, Abeykoon JP, Hu M, Young JR, Shah MV, Bennani NN, Call TG, Hook CC, Pardanani A, Inwards DJ, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Goyal G, et al. Among authors: koster mj. Am J Hematol. 2021 May 1;96(5):E146-E150. doi: 10.1002/ajh.26119. Epub 2021 Feb 19. Am J Hematol. 2021. PMID: 33539584 Free PMC article. No abstract available.
149 results